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Common variable immunodeﬁciency (CVID) is the most frequent primary immunodeﬁciency in adults
and children. We herein report a case of CVID, who was misdiagnosed with asthma due to wheezing
episodes and relatively late onset. A 51-year-old woman had suffered from recurrent upper and lower
airway infection for recent 2 years. She repeated wheezing attacks and was treated as asthma exacer-
bation triggered by infection. She was referred to our hospital for investigation and treatment. Lung
function tests showed no reversibility of FEV1 by b-adrenergic agonist, but the increase of V50/V25. Chest
CT showed slight to moderate bronchial wall thickening and bronchiectasis. After that, she suffered from
pneumonia with wheezing attacks twice a month, and immunodeﬁciency was strongly suspected. Her
blood tests showed marked decreases of all classes of immunoglobulin and nearly lack of memory B cells,
NKT cells and plasmacytoid dendritic cells. She was diagnosed with CVID, and was treated with
replacement of gammaglobulin. Thereafter, her wheezing episodes with infection were remarkably
improved. Because the delay of diagnosis with CVID likely causes poor mortality and morbidity, a pos-
sibility of CVID should be considered in patients with frequent asthma-like symptoms due to recurrent
airway infection.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Common variable immunodeﬁciency (CVID) is the most
frequent cause of primary immunodeﬁciency characterized by hy-
pogammaglobulinemia, recurrent infection and poor response to
vaccination [1e4]. The diagnosis of CVID tends to be delayed
compared to other primary immunodeﬁciencies, because some
cases are late onset. Besides, episodic airway infection causes
airway remodeling and secondary to bronchial wall thickening or
bronchiectasis. Therefore, there may be a risk of misdiagnosing as
bronchial asthma or other chronic pulmonary disease. We herein
report a case of CVID who had been treated as bronchial asthma
because of wheezing attacks.oki).
Ltd. This is an open access article u2. Case report
A 51-year-old woman had suffered from recurrent airway
infection and otitis media for recent two years. At ﬁrst, she
visited primary care clinic and she was diagnosed with asthma
attack. After that, wheezing episodes recurred and she had been
treated with antibiotics and oral glucocorticoid as well as
bronchodilators. In addition, she received a pneumococcal
polysaccharide vaccine (Pneumovax@) to prevent recurrent
airway infection. Despite of these procedures, she repeated
wheezing episodes and she was referred to our hospital for
further investigation and treatment. She had no past medical
history, no smoking history and no allergies. No notable family
history of immunodeﬁciency was detected. As she was working
as a child minder, she had a risk of frequent sick contact. Lung
function tests showed no reversibility of FEV1 by the b-adren-
ergic agonist salbutamol, but V50/V25 in ﬂow-volume curve was
elevated to 4.55, suggesting the existence of peripheral airwaynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Flow-volume curve was almost overlapped before and after inhalation of b2-
stimulant. It revealed no reversibility after inhalation. Although both %VC and FEV 1%
were within normal limit, the ﬂow-volume curve was convex downward and the level
of V50/V25 was increased.
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chial wall thickening and bronchiectasis, and she was given a
combination of the inhaled corticosteroid (ICS) budesonide and
the long-acting badrenergic agonist formoterol. After that, she
visited our hospital because of fever of 39 C and wet cough, and
she was immediately hospitalized. Auscultation of the lungs
showed wheezes and coarse crackles. On laboratory ﬁndings,
white blood cell count increased to 12350/mL (neutrophil 83.1%,
eosinophil 0.3%). The level of C reactive protein was elevated at
1.77 mg/dL. In chest CT taken on admission, inﬁltrative shadow
in right lower lobe and centrilobular nodular shadow in left
upper lobe accompanied by bronchial wall thickening and
bronchiectasis were noted (Fig. 2A, B). Splenomegaly was also
observed (Fig. 2C). Because she was positive for urine pneumo-
coccal antigen, she was diagnosed with pneumococcal pneu-
monia. Ceftriaxone was given and her symptoms were promptly
improved. Fractional expiratory nitric oxide (FeNO) level
(13 ppb) was low, and there was no eosinophilia in sputum and
blood. Because the diagnosis of her asthma was unlikely and
treatment with ICS could increase the risk of infection, ICS was
discontinued and she was then followed at our outpatient
department.
One month after discharge, her pneumonia and wheezing
reoccurred and she was emergently admitted. Because of recurrent
upper and lower airway infection and poor response to vaccination,immunodeﬁciency was strongly suspected. Then, all of immuno-
globulin levels revealed to be markedly decreased (Table 1). Be-
sides, nearly lack of memory B cells, NKT cells and plasmacytoid
dendritic cells which play an important role in the defense against
viral infection were also found from immunological analysis of
peripheral lymphocyte by ﬂow cytometry. Differential diagnosis
was excluded from bone marrow examination, negative ﬁndings
for immunodeﬁciency viruses and no use of immunosuppressive
drugs, and shewas ﬁnally diagnosed with CVID. After the diagnosis,
antibiotic prophylaxis and immunoglobulin replacement therapy
were initiated. Thereafter, wheezing episodes disappeared and the
frequency and severity of airway infection were remarkably
decreased, although the slight peripheral airway obstruction in
lung function tests was not changed.3. Discussion
The course of this patient provides two important clinical sug-
gestions. This case had been treated with corticosteroid according
to the diagnosis of bronchial asthma for a long time despite severe
immunocompromised condition. First, a large majority of cases of
CVID are diagnosed from childhood to 30-year-old. However, in this
case, she was diagnosed at 51-year-old, which is abnormally older
compared with usual cases. Second, CVID should be considered as
differential diagnosis if immunodeﬁciency is suspected from clin-
ical course. Wheezing is generally observed in obstructive condi-
tions of the airways such as asthma, bronchiolitis, chronic
obstructive pulmonary disease and pulmonary edema. This case
was initially diagnosed with bronchial asthma, because bronchial
wall thickening and bronchiectasis were supposed to be airway
remodeling in difﬁcult asthma. However, the lung function tests
only showed slight peripheral airway obstruction. Therefore, the
cause of wheezing episodes in our case may be associated with
airway narrowing with sputum and airway inﬂammation derived
from recurrent airway infection. Furthermore, this patient had very
low IgE and low exhaled NO, which should have been a clue that
the patient didn't have asthma. Maarschalk-Ellerbroek et al. [5]
reported that signiﬁcant pulmonary abnormalities in CVID were
detected in over 50% consisting of airway abnormalities in 30% and
intestinal lung disease in 34%. Lung involvement distributes to
patient's mortality and morbidity for CVID [6,7]. So it is important
to detect as soon as possible. Although CVID is descriptive term for
a heterogeneous group of patients with a primary antibody deﬁ-
ciency syndrome, some cases show not only memory B cell
dysfunction but also other immunodeﬁciency. Similarly in this case,
the patient showed marked decreases in all classes of immuno-
globulin and memory B cells, NKT cells, and plasmacytoid dendritic
cells. Because it has recently been shown that both B cell and T cell
dysfunction in CVID increases the risk of infection and prevalence
of malignancy [8], this case needs an intensive follow-up.
Replacement immunoglobulin is the standard treatment
for patients with CVID. Recommended target trough level of
serum IgG is around 500e700 mg/dL in recent published
guidelines and literature [9,10]. These data are not based on
strong evidence and the doses of immunoglobulin should be
selected individually to keep a patient free of bacterial in-
fections. It is recommended for the cases with complication (i.e.
splenomegaly or bronchiectasis) to keep higher trough level of
IgG [11], and the level in this case was set as 500 mg/dL. After
the immunoglobulin replacement therapy, the degree of fre-
quency and severity of infection as well as wheezing episodes
were decreased, but higher IgG level might be favorable in
this case because of complication with splenomegaly and
bronchiectasis.
Table 1
Laboratory ﬁndings.
Criterion value
Immunoglobulin
IgG (mg/dL) 74 800e1700
IgA (mg/dL) <10 110e410
IgM (mg/dL) 5 33e260
IgD (mg/dL) <0.6 <9
IgE (IU/mL) <2.0 <173
T cell: CD3þ/Lym (%) 89 60.3e83.5
B cell: CD19þ/Lym (%) 3.35 4.9e20.9
NK cell: CD16 þ 56þ/Lym (%) 2.49 4e17
B cell fraction
memory B cell: CD27þ/CD19þ (%) 6.1
IgM memory B cell: CD27 þ IgDþ/CD19þ (%) 3.6 7.9e36
switched memory B cell: CD27þIgD-/CD19þ (%) 2.5 6.5e33
T cell fraction
helper T cell: CD4þ/CD3þ (%) 59 25.0e54.0
suppressor T cell: CD8þ/CD3þ (%) 37.9 23.0e56.0
memory T cell: CD45ROþ/CD3þ4þ (%) 90.9 12e34
naïve T cell: CD45RA þ CD31þ/CD3þ4þ (%) 57.5 7e33
regulatory T cell: CD25highCD127dull/CD3þ4þ (%) 0.87 N/A
NKT cell: TCRVa24 þ Vb11þ/CD3þ (%) 0 0.03e0.12
Dendritic cell (mean ± SD)
plasmacytoid dendritic cell (%/WBC) 0.015 0.16 ± 0.08
myeloid dendritic cell (%/WBC) 0.15 0.28 ± 0.1
Fig. 2. Inﬁltrative shadow which suggests pneumonia in right lower lobe (A). Centrilobular nodular shadow in left upper lobe with slight to moderate bronchial wall thickening and
bronchiectasis (B). Splenomegaly (C).
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